Asset Details
Do you wish to reserve the book?
CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals
Do you wish to request the book?
CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
CRISPR-Cas9 Genome Editing Tool for the Production of Industrial Biopharmaceuticals
2020
Overview
A broad range of cell lines with characteristic features are used as bio-factories to produce recombinant proteins for basic research and therapeutic purposes. Genetic engineering strategies have been used to manipulate the genome of mammalian cells, insects, and yeasts for heterologous expression. One reason is that the glycosylation pattern of the expression hosts differs somehow from mammalian cells, which may cause immunogenic reactions upon administration in humans. CRISPR-Cas9 is a simple, efficient, and versatile genome engineering tool that can be programmed to precisely make double-stranded breaks at the desired loci. Compared to the classical genome editing methods, a CRISPR-Cas9 system is an ideal tool, providing the opportunity to integrate or delete genes from the target organisms. Besides broadened applications, limited studies have used CRISPR-Cas9 for editing the endogenous pathways in expression systems for biopharmaceutical applications. In the present review, we discuss the use of CRISPR-Cas9 in expression systems to improve host cell lines, increase product yield, and humanize glycosylation pathways by targeting intrinsic genes.
Publisher
Springer US,Springer Nature B.V
Subject
/ Chemistry and Materials Science
/ CRISPR
/ Editing
/ Genes
/ Genomes
/ heterologous gene expression
/ Insects
/ Mammals
/ Review
/ Yeast
